| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| 5-Pyrimidinecarboxamide, 4-[[2-(hydroxymethyl)phenyl]amino]-2-[(1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinyl)amino]- |
HPK1對照 |
2739844-28-9 |
詳細(xì)
|
| AZ-20 |
AZ20 |
1233339-22-4 |
詳細(xì)
|
| Plazomicin |
硫酸普拉米星 |
1154757-24-0 |
詳細(xì)
|
| Hydrazinecarboxamide, 2-[(2,4-difluorophenyl)methylene]-N-[3-fluoro-4-[[6-methoxy-7-[3-(4-methyl-1-piperidinyl)propoxy]-4-quinolinyl]oxy]phenyl]-, (2E)- |
c-Met抑制劑 |
1428787-71-6 |
詳細(xì)
|
| BI 2536 |
BI 2536 |
755038-02-9 |
詳細(xì)
|
| BI 6727 |
N-[反式-4-[4-(環(huán)丙基甲基)-1-哌嗪基]環(huán)己基]-4-[[(7R)-7-乙基-5,6,7,8-四氫-5-甲基-8-異丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺 |
755038-65-4 |
詳細(xì)
|
| RO3280 |
RO3280 |
1062243-51-9 |
詳細(xì)
|
| TAK-960 |
TAK960 |
1137868-52-0 |
詳細(xì)
|
| NMS-P937 |
4,5-二氫-1-(2-羥基乙基)-8-[[5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯基]氨基]-1H-吡唑并[4,3-H]喹唑啉-3-甲酰胺 |
1034616-18-6 |
詳細(xì)
|
| t-AUCB |
反式AUCB |
885012-33-9 |
詳細(xì)
|
| 4-amino-N-(Trans-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)-3-methoxybenzamide |
BI-6727的側(cè)鏈中間體 |
882660-39-1 |
詳細(xì)
|
| 2-CHLORO-9-CYCLOPENTYL-7,7-DIFLUORO-5-METHYL-8,9-DIHYDRO-5H-PYRIMIDO[4,5-B][1,4]DIAZEPIN-6(7H)-ONE |
RO3280母核中間體 |
1062246-03-0 |
詳細(xì)
|
| Octahydroaminoacridine |
琥珀八氫氨吖啶 |
866245-79-6 |
詳細(xì)
|
| Pradofloxacin |
普多沙星 |
195532-12-8 |
詳細(xì)
|
| (R)-2-chloro-7-ethyl-8-isopropyl-5-methyl-7,8-dihydropteridin-6(5H)-one |
BI-6727的母核中間體 |
877676-50-1 |
詳細(xì)
|
| 1-PHENYL-1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONE |
BML-280中間體 |
1021-25-6 |
詳細(xì)
|
| 2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-6-chloro-3,8-dimethylquinazolin-4(3H)-one |
氯蟲苯甲酰胺雜質(zhì) |
438450-43-2 |
詳細(xì)
|
| Ozagrel Impurity 16 |
奧扎格雷雜質(zhì)1（順式異構(gòu)體） |
143945-86-2 |
詳細(xì)
|
| Ozagrel Impurity 7 |
奧扎格雷雜質(zhì)7 |
883903-91-1 |
詳細(xì)
|
| PDP-LA |
化合物 T28353 |
861891-72-7 |
詳細(xì)
|
| 4-aMino-3-Methoxy-N-(1-Methylpiperidin-4-yl)benzaMide |
4-氨基-3-甲氧基-N-(1-甲基哌啶-4-基)苯甲酰胺 |
876126-60-2 |
詳細(xì)
|
| GSK 2256294 |
SEH抑制劑(GSK2256294A) |
1142090-23-0 |
詳細(xì)
|
| t-TUCB |
UC-1728 |
948304-40-3 |
詳細(xì)
|
| TPPU |
CS-2462 |
1222780-33-7 |
詳細(xì)
|
| EC5026 |
EC-5026 |
1809885-32-2 |
詳細(xì)
|
| SN32976 |
SN-32976 |
1246202-11-8 |
詳細(xì)
|
| ZSTK474 |
2-(2-二氟甲基苯并咪唑-1-基)-4,6-二嗎啉基-1,3,5-三嗪 |
475110-96-4 |
詳細(xì)
|
| CNX1351 |
CNX1351 |
1276105-89-5 |
詳細(xì)
|
| Radezolid |
雷德唑來 |
869884-78-6 |
詳細(xì)
|
| Orbifloxacin |
奧比沙星 |
113617-63-3 |
詳細(xì)
|
| BML-280 |
消旋-7-氧代普拉克索二鹽酸鹽 |
1158347-73-9 |
詳細(xì)
|
| JH-VIII-157-02 |
化合物 T15612 |
1639422-97-1 |
詳細(xì)
|
| GDC-0941 |
GDC-0941 |
957054-30-7 |
詳細(xì)
|
| LCL161 |
LCL161 |
1005342-46-0 |
詳細(xì)
|
| AZ-33 |
AZ-33 |
1370290-34-8 |
詳細(xì)
|
| (R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7,8-dihydropteridin-6(5H)-one |
BI-2536的母核中間體 |
755039-55-5 |
詳細(xì)
|
| Testosterone Tridecanoate |
睪酮13烷酸酯 |
488836-58-4 |
詳細(xì)
|
| Dexecadotril |
八氫氨吖啶 |
13415-07-1 |
詳細(xì)
|
| GSK-2110183C |
福瑞賽替 |
1047644-62-1 |
詳細(xì)
|
| Levosimendan |
左西孟旦 |
141505-33-1 |
詳細(xì)
|
| 4-(TRIFLUOROMETHYL)BENZHYDRAZIDE |
4-(三氟甲基)亞苯基肼 |
339-59-3 |
詳細(xì)
|
| Tecovirimat |
特考韋瑞 |
816458-31-8 |
詳細(xì)
|
| Levalbuterol hydrochloride |
鹽酸左沙丁胺醇 |
50293-90-8 |
詳細(xì)
|
| Lanraplenib GS-9876 |
GS-9876 |
1800046-95-0 |
詳細(xì)
|
| HPK1-IN-7 |
1(3H)-Isobenzofuranone, 5-[[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-5-(1,3,4-oxadiazol-2-yl)-2-pyrimidinyl]amino]-3,3-dimethyl- |
2320462-65-3 |
詳細(xì)
|
| 4-[(trans-4-Aminocyclohexyl)oxy]benzoic acid |
t-AUCB中間體 |
1394012-10-2 |
詳細(xì)
|
| Clotrimazole |
克霉唑 |
23593-75-1 |
詳細(xì)
|
|
邁華替尼 |
1417695-74-9 |
詳細(xì)
|
| Vitamin A |
視黃醇 |
68-26-8 |
詳細(xì)
|
| Maihuatini Impurity 5 |
麥華替尼雜質(zhì)5 |
1417695-78-3 |
詳細(xì)
|
| 4-(5-chloro-2-(4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl)phenyl)-2,5-dimethoxypyridine |
4-[5-氯-2-[4-(三氟甲基)-1H-1,2,3-三唑-1-基]苯基]-2,5-二甲氧基吡啶 |
2376389-31-8 |
詳細(xì)
|
| 2(1H)-Pyridinone, 4-[5-chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl]-5-methoxy- |
4-[5-氯-2-[4-(三氟甲基)-1H-1,2,3-三唑-1-基]苯基]-5-甲氧基吡啶-2(1H)-酮 |
2376389-33-0 |
詳細(xì)
|
| 1(2H)-Pyridineacetamide, N-[4-(aminocarbonyl)-3-fluorophenyl]-4-[5-chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl]-α-ethyl-5-methoxy-2-oxo-, (αS)- |
ASUNDEXIAN |
2064121-65-7 |
詳細(xì)
|
| (E)-1-(4-(3-chloropropoxy)-5-methoxy-2-nitrophenyl)-3-(dimethylamino)prop-2-en-1-one |
|
1449763-02-3 |
詳細(xì)
|
| 1-(4-(3-Chloropropoxy)-5-methoxy-2-nitrophenyl)ethanone |
|
1160707-44-7 |
詳細(xì)
|
| 7-(3-chloropropoxy)-6-methoxyquinolin-4-ol |
|
1494544-04-5 |
詳細(xì)
|
| L-Threonine, N-(4-ethynylbenzoyl)-, methyl ester |
CHIR090-中間體1 |
728878-24-8 |
詳細(xì)
|
| L-Threonine, N-[4-[2-[4-(4-morpholinylmethyl)phenyl]ethynyl]benzoyl]-, methyl ester |
CHIR090-中間體1 |
728878-12-4 |
詳細(xì)
|
| CHIR090 |
CHIR 090 |
728865-23-4 |
詳細(xì)
|
| Benzoic acid, 5-cyclopropyl-4-[[1-[(1S)-1-(3,5-dichlorophenyl)ethyl]-4-piperidinyl]methoxy]-2-fluoro-, methyl ester |
GDC-0310中間體4 |
2448100-15-8 |
詳細(xì)
|
| methyl 5-cyclopropyl-2-fluoro-4-(piperidin-4-ylmethoxy)benzoate hydrochloride |
GDC-0310中間體3 |
1786393-45-0 |
詳細(xì)
|
| 4 Methyl 5-cyclopropyl-2-fluoro-4- (piperidin-4-ylmethoxy) benzoate |
GDC-0310中間體3 |
1786392-83-3 |
詳細(xì)
|
| 1-Piperidinecarboxylic acid, 4-[[2-cyclopropyl-4-[(1,1-dimethylethoxy)carbonyl]-5-fluorophenoxy]methyl]-, 1,1-dimethylethyl ester |
GDC-0310中間體2 |
1788072-30-9 |
詳細(xì)
|
| 1-Piperidinecarboxylic acid, 4-[[2-chloro-4-[(1,1-dimethylethoxy)carbonyl]-5-fluorophenoxy]methyl]-, 1,1-dimethylethyl ester |
GDC-0310中間體1 |
1788072-29-6 |
詳細(xì)
|
| GDC-0310 |
GDC-0310 |
1788063-52-4 |
詳細(xì)
|
| GDC-0276 |
GDC0276 |
1494581-70-2 |
詳細(xì)
|
| Benzamide, 4-[[(2R)-2-bromo-1-oxobutyl]amino]-2-fluoro- |
(R)-4-(2-溴丁酰氨基)-2-氟苯甲酰胺 |
2376389-34-1 |
詳細(xì)
|
| 4-(3-chloropropoxy)-3-methoxyacetophenone |
4-(3-氯丙氧基)-3-甲氧基苯乙酮 |
58113-30-7 |
詳細(xì)
|
| N,N'-((1S,2S)-cyclohexane-1,2-diyl)bis(N-methylpicolinamide) |
|
474937-35-4 |
詳細(xì)
|
| Pimavanserin Tartrate |
酒石酸哌馬色林 |
706782-28-7 |
詳細(xì)
|
| Cefazedone |
頭孢西酮酸 |
56187-47-4 |
詳細(xì)
|
| 1，1-DIMETHYLBIGUANIDE HYDROCHLORIDE |
鹽酸二甲雙胍 |
15537-72-1 |
詳細(xì)
|
| Sulbenicillin sodium |
磺芐西林鈉 |
28002-18-8 |
詳細(xì)
|
| 1,8-Naphthalic anhydride |
1,8萘酐 |
81-84-5 |
詳細(xì)
|
| 4(1H)-Quinolinone, 6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]- |
6-甲氧基 -7-(3-吡咯烷 -1-基)丙氧基)喹啉 -4(1H)-酮 |
205448-56-2 |
詳細(xì)
|
| 1H-Indole-3-carboxylic acid, 6-bromo-5-hydroxy-4-(1H-imidazol-1-ylmethyl)-1-methyl-2-[(phenylsulfinyl)methyl]-, ethyl ester |
艾米朵爾 |
865171-50-2 |
詳細(xì)
|
| Plogosertib (CYC140) |
化合物 PLOGOSERTIB |
1137212-79-3 |
詳細(xì)
|